Surveillance Snapshot: Cases of Service Member Meningococcal Disease Reported to the Naval Health Research Center Laboratory-Based Meningococcal Disease Surveillance Program, 2006-2014
NAVAL HEALTH RESEARCH CENTER SAN DIEGO CA
Pagination or Media Count:
Rates of meningococcal disease have decreased more than 90 since the early 1970s, and in recent years, the incidence rates in the military and general populations have become equivalent. Of the 33 cases reported, 31 have a record of receipt of quadrivalent meningococcal vaccine before their illnesses for the other two cases, the vaccine history was unavailable. All fatal cases n6 had been immunized. Among the 33 cases, serogroups of Neisseria meningitidis identified were type B n10, type C n8, type Y n11, and undetermined n4. The distribution of serogroups among the fatal cases showed two each of types B, C, and Y. Among the six most recent cases 2012-2014, four were infected with group B and there was one each of groups C and Y. Serogroup B is not covered in the available quadrivalent vaccines which protect against serogroups A, C, W-135, and Y licensed in the United States. NHRC identifies cases of meningococcal disease through the Services reportable events systems and regular reports from the Navy and Marine Corps Public Health Center and the Armed Forces Health Surveillance Center, as well as notification from sites cognizant of the surveillance.
- Military Forces and Organizations